[Drug Design].
Abanades
Sergio
S
Farré
Magí
M
D015195:Drug Design; D006213:Hallucinogens / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000008:administration & dosage* / Q000009:adverse effects; D019966:Substance-Related Disorders / Q000209:etiology*
D006213:Hallucinogens; D018817:N-Methyl-3,4-methylenedioxyamphetamine